BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 26611557)

  • 41. Opportunistic infections associated with Janus kinase inhibitor treatment for rheumatoid arthritis: A structured literature review.
    Winthrop K; Isaacs J; Calabrese L; Mittal D; Desai S; Barry J; Strengholt S; Galloway J
    Semin Arthritis Rheum; 2023 Feb; 58():152120. PubMed ID: 36347212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Ambulatory therapy and prevention of the most frequent HIV-associated opportunistic infections].
    Malinverni R; Blatter M
    Schweiz Med Wochenschr; 1991 Aug; 121(34):1194-204. PubMed ID: 1925448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased risk of opportunistic infection in early rheumatoid arthritis.
    Kim H; Cho SK; Lee J; Bae SC; Sung YK
    Int J Rheum Dis; 2019 Jul; 22(7):1239-1246. PubMed ID: 31090187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.
    Yun H; Xie F; Delzell E; Chen L; Levitan EB; Lewis JD; Saag KG; Beukelman T; Winthrop K; Baddley JW; Curtis JR
    Arthritis Care Res (Hoboken); 2015 May; 67(5):731-6. PubMed ID: 25201241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opportunistic infections in patients with idiopathic inflammatory myopathies.
    Redondo-Benito A; Curran A; Villar-Gomez A; Trallero-Araguas E; Fernández-Codina A; Pinal-Fernandez I; Rodrigo-Pendás JÁ; Selva-O'Callaghan A
    Int J Rheum Dis; 2018 Feb; 21(2):487-496. PubMed ID: 29314762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serious infections associated with anticytokine therapies in the rheumatic diseases.
    Giles JT; Bathon JM
    J Intensive Care Med; 2004; 19(6):320-34. PubMed ID: 15523118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study.
    Ohmura SI; Naniwa T; Tamechika SY; Miyamoto T; Shichi D; Kazawa N; Iwagaitsu S; Maeda S; Wada JI; Niimi A
    J Infect Chemother; 2019 Apr; 25(4):253-261. PubMed ID: 30642768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions: a systematic review with recommendations for prophylaxis.
    Gonzalez Santiago TM; Wetter DA; Kalaaji AN; Limper AH; Lehman JS
    Int J Dermatol; 2016 Aug; 55(8):823-30. PubMed ID: 27009930
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary.
    Côté-Daigneault J; Peerani F; MacMahon E; Delaporte E; Rahier JF; Colombel JF
    Inflamm Bowel Dis; 2016 Oct; 22(10):2538-47. PubMed ID: 27598743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medical Pearl: Pneumocystis pneumonia prophylaxis for patients on chronic systemic corticosteroids.
    Lemaire CM; Browning JC; Hsu S
    J Am Acad Dermatol; 2006 Jul; 55(1):124-5. PubMed ID: 16781304
    [No Abstract]   [Full Text] [Related]  

  • 51. Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole.
    Park JW; Curtis JR; Kim MJ; Lee H; Song YW; Lee EB
    Arthritis Res Ther; 2019 Sep; 21(1):207. PubMed ID: 31521185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort.
    Yang SC; Lai YY; Huang MC; Tsai CS; Wang JL
    Lupus; 2018 Oct; 27(11):1819-1827. PubMed ID: 30103646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lower Extremity Edema, Anxiety, and Cyanosis During Chemoradiation Therapy for Glioblastoma.
    Rizk N; Kamiya-Matsuoka C; Tremont-Lukats IW
    JAMA Oncol; 2016 Feb; 2(2):265-6. PubMed ID: 26540389
    [No Abstract]   [Full Text] [Related]  

  • 54. Predictive factors of pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids.
    Herrou J; De Lastours V
    Ann Rheum Dis; 2020 Feb; 79(2):e23. PubMed ID: 30487148
    [No Abstract]   [Full Text] [Related]  

  • 55. Safety issues in vasculitis: infections and immunizations in the immunosuppressed host.
    Isada CM
    Cleve Clin J Med; 2012 Nov; 79 Suppl 3():S38-45. PubMed ID: 23203645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials.
    Cohen SB; Tanaka Y; Mariette X; Curtis JR; Lee EB; Nash P; Winthrop KL; Charles-Schoeman C; Thirunavukkarasu K; DeMasi R; Geier J; Kwok K; Wang L; Riese R; Wollenhaupt J
    Ann Rheum Dis; 2017 Jul; 76(7):1253-1262. PubMed ID: 28143815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crohn's Disease Activity and Concomitant Immunosuppressants Affect the Risk of Serious and Opportunistic Infections in Patients Treated With Adalimumab.
    Osterman MT; Sandborn WJ; Colombel JF; Peyrin-Biroulet L; Robinson AM; Zhou Q; Lewis JD
    Am J Gastroenterol; 2016 Dec; 111(12):1806-1815. PubMed ID: 27670599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
    Furer V; Rondaan C; Heijstek MW; Agmon-Levin N; van Assen S; Bijl M; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; de Thurah A; Landewé RB; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; Elkayam O
    Ann Rheum Dis; 2020 Jan; 79(1):39-52. PubMed ID: 31413005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A co-infection of varicella-zoster virus and Pneumocystis jirovecii in a non-HIV immunocompromised patient: a case report.
    Muramatsu H; Kuriyama A; Anzai Y; Ikegami T
    BMC Infect Dis; 2019 Dec; 19(1):1092. PubMed ID: 31888503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis.
    Winthrop KL; Park SH; Gul A; Cardiel MH; Gomez-Reino JJ; Tanaka Y; Kwok K; Lukic T; Mortensen E; Ponce de Leon D; Riese R; Valdez H
    Ann Rheum Dis; 2016 Jun; 75(6):1133-8. PubMed ID: 26318385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.